https://www.selleckchem.com/pr....oducts/anacardic-aci
48 per quality-adjusted life year at two years. Primary was associated with a lower incremental cost-effectiveness ratio at two years (primary £7596.76 vs. revision £11,748.51). The estimated post-operative life expectancy of the cohort was 6.9 years with a projected cost per quality-adjusted life year of £2438.78. Reverse total shoulder arthroplasty provides a cost-effective intervention with excellent patient outcomes at two years post-operatively. Reverse total shoulder arthroplasty provides a cost-effective intervention with
Like
Comment
Share
